SeekIn Receives CE Mark Approval for SeekInCare® Pan Cancer Early Detection Test

This First-of-its-Kind Blood-based Pan Cancer Early Detection Test Combines Protein Markers, Genomic and Epigenetic Features of Cancer in Blood

· Press Releases

SeekIn Inc, the leader in blood-based cancer early detection and monitoring technology, today announced the CE (Conformité Européenne) Mark for SeekInCare® Cancer Detection Kit and is now ready to launch this test in European markets.

 

Billet précédentBillet suivant